TY  - JOUR

T1  - Cost-effectiveness of adalimumab for early-stage Dupuytren’s disease

JO  - Bone & Joint Open

PY  - 2022/11/15

AU  - Dakin H

AU  - Rombach I

AU  - Dritsaki M

AU  - Gray A

AU  - Ball C

AU  - Lamb SE

AU  - Nanchahal J

ED  - 

DO  - DOI: 10.1302/2633-1462.311.bjo-2022-0103.r2

PB  - The British Editorial Society of Bone & Joint Surgery

VL  - 3

IS  - 11

SP  - 898

EP  - 906

Y2  - 2024/10/22

ER  -